Upper digestive tract disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) patients who proposed upper gastrointestinal endoscopy; (2) aged 18 to 70 years, male or female; (3) no cognitive dysfunction; (4) voluntary participation in this clinical trial, informed consent has been signed.
Exclusion criteria
Exclusion criteria: (1) American society of anesthesiologists (ASA) grades III ~ VI. (2) long-term use of anticoagulant therapy or the use of anticoagulant drugs within 1 week before enrollment; Or patients with a history of drug abuse, allergy to sedatives, or other risks of anesthesia. (3) severe spine or thoracic deformity. (4) severe history of esophageal and gastric varicose veins. (5) the anatomical structure of pharynx/esophagus/stomach/duodenum is obviously malformed/narrow. (6) patients with massive gastrointestinal bleeding or suspected gastrointestinal perforation or erosive esophageal burns in the acute stage or edema stage. (7) patients with severe diseases of various systems, including but not limited to aortic aneurysm, cardiopulmonary insufficiency, and acute stage of stroke. (8) patients with pregnancy, lactation or recent family planning. (9) patients enrolled in other clinical trials within the first 30 days. (10) patients considered inappropriate by the investigator to participate in this clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall image consistency;Complete machine safety;Vital signs;Adverse events; | — |
Secondary
| Measure | Time frame |
|---|---|
| Image quality rate;System stability; | — |
Countries
China
Contacts
Nanfang Hospital, Southern Medical University